{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:36:49Z","timestamp":1793320609228,"version":"4.5.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jaut.2021.102619","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T08:45:34Z","timestamp":1614415534000},"page":"102619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["Regulatory T cells in autoimmune hepatitis: an updated overview"],"prefix":"10.1016","volume":"119","author":[{"given":"Maria Serena","family":"Longhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102619_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fimmu.2012.00178","article-title":"Multiple treg suppressive modules and their adaptability","volume":"3","author":"Wing","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/icb.2009.8","article-title":"CD8 regulatory T cells: what's old is now new","volume":"87","author":"Wang","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jaut.2021.102619_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4+ T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102619_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1189\/jlb.0309118","article-title":"Editorial: NKT cells: to suppress or not to suppress, that is the question","volume":"86","author":"Subleski","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2021.102619_bib6","first-page":"39","article-title":"Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.184.2.387","article-title":"Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation","volume":"184","author":"Asano","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib11","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/eji.200526189","article-title":"Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level","volume":"35","author":"Roncador","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/86302","article-title":"Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide","volume":"2","author":"Jordan","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/icb.2010.123","article-title":"Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes","volume":"89","author":"Wirnsberger","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jaut.2021.102619_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ni.2554","article-title":"Regulatory T cells: recommendations to simplify the nomenclature","volume":"14","author":"Abbas","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib16","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1084\/jem.20040249","article-title":"In vivo instruction of suppressor commitment in naive T cells","volume":"199","author":"Apostolou","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1265","article-title":"Inducing and expanding regulatory T cell populations by foreign antigen","volume":"6","author":"Kretschmer","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ni1504","article-title":"Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10","volume":"8","author":"Maynard","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib19","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/eji.200838105","article-title":"DNA methylation controls Foxp3 gene expression","volume":"38","author":"Polansky","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","article-title":"T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development","volume":"37","author":"Ohkura","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102619_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2021.102619_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coi.2009.05.007","article-title":"Plasticity of CD4(+) FoxP3(+) T cells","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2013.10.016","article-title":"Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response","volume":"39","author":"Bailey-Bucktrout","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102619_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib26","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1172\/JCI57456","article-title":"GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice","volume":"121","author":"Wohlfert","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2021.102619_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/ni.2006","article-title":"The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells","volume":"12","author":"Cretney","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.aaa9420","article-title":"MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells","volume":"349","author":"Sefik","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaut.2021.102619_bib29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.aac4263","article-title":"MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORgammat(+) T cells","volume":"349","author":"Ohnmacht","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaut.2021.102619_bib30","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/eji.200526106","article-title":"TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation","volume":"35","author":"Kullberg","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni1180","article-title":"Mechanisms of suppression by suppressor T cells","volume":"6","author":"von Boehmer","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1084\/jem.20040685","article-title":"T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells","volume":"201","author":"Fahlen","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1084\/jem.194.5.629","article-title":"Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta","volume":"194","author":"Nakamura","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib34","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1084\/jem.183.6.2669","article-title":"A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells","volume":"183","author":"Powrie","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.190.7.995","article-title":"An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation","volume":"190","author":"Asseman","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib36","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.4049\/jimmunol.166.6.3789","article-title":"IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo","volume":"166","author":"Hara","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2021.102619_bib38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102619_bib39","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2021.102619_bib41","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.cdd.4402220","article-title":"Involvement of cellular death in TRAIL\/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells","volume":"14","author":"Ren","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jaut.2021.102619_bib42","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.182.3.1469","article-title":"Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis","volume":"182","author":"Strauss","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","article-title":"Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance","volume":"27","author":"Cao","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102619_bib44","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.174.4.1783","article-title":"Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism","volume":"174","author":"Gondek","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib45","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","article-title":"Activated CD4+CD25+ T cells selectively kill B lymphocytes","volume":"107","author":"Zhao","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102619_bib46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","article-title":"Human T regulatory cells can use the perforin pathway to cause autologous target cell death","volume":"21","author":"Grossman","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102619_bib47","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.autrev.2013.04.005","article-title":"Enhanced killing activity of regulatory T cells ameliorates inflammation and autoimmunity","volume":"12","author":"Askenasy","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102619_bib48","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.4049\/jimmunol.170.7.3631","article-title":"Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway","volume":"170","author":"Kashio","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib49","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib50","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20062129","article-title":"Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression","volume":"204","author":"Bopp","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib51","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1073\/pnas.1009463108","article-title":"Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1)","volume":"108","author":"Vaeth","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2021.102619_bib52","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/eji.201141578","article-title":"Cyclic AMP underpins suppression by regulatory T cells","volume":"42","author":"Bodor","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib53","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1056\/NEJMra1205750","article-title":"Purinergic signaling during inflammation","volume":"367","author":"Eltzschig","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib54","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib55","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib56","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.1424792112","article-title":"Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis","volume":"112","author":"Peres","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2021.102619_bib57","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X","article-title":"CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells","volume":"30","author":"Cederbom","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib58","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaut.2021.102619_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib60","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib61","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","article-title":"Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease","volume":"186","author":"Mao","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2021.102619_bib63","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2013.11.009","article-title":"Diagnostic criteria of autoimmune hepatitis","volume":"13","author":"Liberal","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102619_bib64","first-page":"1433","volume":"382","author":"Heneghan","year":"2013","journal-title":"Autoimmune hepatitis. Lancet"},{"key":"10.1016\/j.jaut.2021.102619_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions","volume":"14","author":"Grant","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102619_bib66","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/jhep.2003.50191","article-title":"MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes","volume":"37","author":"Herkel","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2010.10.005","article-title":"Liver antigen-presenting cells","volume":"54","author":"Crispe","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2021.102619_bib68","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.1840120208","article-title":"Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease","volume":"12","author":"Lobo-Yeo","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib69","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0090-1229(90)90052-R","article-title":"Liver-derived T cell clones in autoimmune chronic active hepatitis: accessory cell function of hepatocytes expressing class II major histocompatibility complex molecules","volume":"54","author":"Franco","year":"1990","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jaut.2021.102619_bib70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/gut.19.4.308","article-title":"Lymphocyte cytotoxicity in chronic active hepatitis: effect of therapy and correlations with clinical and histological changes","volume":"19","author":"Cochrane","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102619_bib71","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0140-6736(76)91472-0","article-title":"Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis","volume":"1","author":"Cochrane","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2021.102619_bib72","article-title":"Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression","volume":"6","author":"Zhao","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102619_bib73","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.autrev.2018.06.008","article-title":"IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases","volume":"17","author":"Beringer","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102619_bib74","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1073\/pnas.75.3.1549","article-title":"Alteration in suppressor cell activity in chronic active hepatitis","volume":"75","author":"Hodgson","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2021.102619_bib75","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM198211183072102","article-title":"Effect of corticosteroids on suppressor-cell activity in \"autoimmune\" and viral chronic active hepatitis","volume":"307","author":"Nouri-Aria","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib76","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(84)91691-X","article-title":"Antigen specific suppressor cell function in autoimmune chronic active hepatitis","volume":"1","author":"Vento","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2021.102619_bib77","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2018.10.008","article-title":"Autoimmune sclerosing cholangitis: evidence and open questions","volume":"95","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102619_bib79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2021.102619_bib80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102619_bib81","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib82","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.22914","article-title":"Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells","volume":"50","author":"Longhi","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib83","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib84","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2012.12.003","article-title":"T-regs in autoimmune hepatitis-systemic lupus erythematosus\/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile","volume":"41","author":"Longhi","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102619_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2021.102619_bib86","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jhep.2014.05.034","article-title":"Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies","volume":"61","author":"Taubert","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2021.102619_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181107","article-title":"Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy","volume":"12","author":"Diestelhorst","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102619_bib88","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hep4.1163","article-title":"Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis","volume":"2","author":"Jeffery","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jaut.2021.102619_bib89","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/hep.27998","article-title":"A novel \"humanized mouse\" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation","volume":"62","author":"Yuksel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143715","article-title":"The role of regulatory CD4 T cells in maintaining tolerance in a mouse model of autoimmune hepatitis","volume":"10","author":"An Haack","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102619_bib91","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/cei.12843","article-title":"The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model","volume":"186","author":"Yuksel","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib92","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"Liberal","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/cei.12956","article-title":"Immunosuppressive drugs affect interferon (IFN)-gamma and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis","volume":"189","author":"Grant","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib94","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2021.102619_bib95","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2020.06.044","article-title":"Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis","volume":"74","author":"Vuerich","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2021.102619_bib96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature06880","article-title":"Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor","volume":"453","author":"Quintana","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2021.102619_bib97","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature06881","article-title":"The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins","volume":"453","author":"Veldhoen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2021.102619_bib98","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12026-019-9068-1","article-title":"Tryptophan-kynurenine profile in pediatric autoimmune hepatitis","volume":"67","author":"Lytton","year":"2019","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2021.102619_bib99","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.1502276","article-title":"Production of proinflammatory cytokines by monocytes in liver-transplanted recipients with de novo autoimmune hepatitis is enhanced and induces TH1-like regulatory T cells","volume":"196","author":"Arterbery","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib100","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3389\/fimmu.2018.01612","article-title":"Inflammasome priming mediated via toll-like receptors 2 and 4, induces Th1-like regulatory T cells in de novo autoimmune hepatitis","volume":"9","author":"Arterbery","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib101","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.22071","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","volume":"47","author":"Longhi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib102","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2012.02.041","article-title":"Inhibition of interleukin-17 promotes differentiation of CD25(-) cells into stable T regulatory cells in patients with autoimmune hepatitis","volume":"142","author":"Longhi","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102619_bib103","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/hep.24039","article-title":"Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis","volume":"53","author":"Longhi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib104","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2014.02.001","article-title":"Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2","volume":"53","author":"Holder","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102619_bib105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhepr.2019.08.001","article-title":"Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis","volume":"1","author":"Oo","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jaut.2021.102619_bib106","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41467-019-09893-5","article-title":"Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines","volume":"10","author":"Umeshappa","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2021.102619_bib107","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/hep.26380","article-title":"Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells","volume":"58","author":"Hardtke-Wolenski","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102619_bib109","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/hep.30059","article-title":"Low-dose interleukin-2 for refractory autoimmune hepatitis","volume":"68","author":"Lim","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib110","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0016-5085(86)90680-3","article-title":"T-lymphocyte sensitization to hepatocyte antigens in autoimmune chronic active hepatitis and primary biliary cirrhosis. Evidence for different underlying mechanisms and different antigenic determinants as targets","volume":"91","author":"Vento","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102619_bib111","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.21123","article-title":"Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis","volume":"43","author":"Lan","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib112","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/cmi.2010.40","article-title":"CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis","volume":"7","author":"Wang","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib113","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","article-title":"Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population","volume":"156","author":"Rong","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib114","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaut.2010.06.004","article-title":"Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis","volume":"35","author":"Bernuzzi","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102619_bib115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fimmu.2017.00031","article-title":"CD28(-) and CD28(low)CD8(+) regulatory T cells: of mice and men","volume":"8","author":"Vuddamalay","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib116","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","article-title":"IL-2 receptor alpha(-\/-) mice and the development of primary biliary cirrhosis","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib117","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.22591","article-title":"Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-\/-) mice","volume":"49","author":"Hsu","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib118","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.22651","article-title":"Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis","volume":"49","author":"Zhang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib119","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaut.2014.01.034","article-title":"Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells","volume":"50","author":"Huang","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102619_bib120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2015.01.011","article-title":"Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis","volume":"59","author":"Wang","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102619_bib121","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2018.07.020","article-title":"Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-gamma secreting cells","volume":"94","author":"Liaskou","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102619_bib122","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.20051911","article-title":"NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis","volume":"203","author":"Irie","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib123","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2013.12.027","article-title":"Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms","volume":"60","author":"Sebode","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2021.102619_bib124","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/hep.30061","article-title":"Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine sclerosing cholangitis","volume":"68","author":"Taylor","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102619_bib125","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib126","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20040180","article-title":"CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes","volume":"199","author":"Tarbell","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102619_bib127","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/eji.200839073","article-title":"Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg","volume":"39","author":"Stephens","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib128","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI17702","article-title":"Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia","volume":"112","author":"Trenado","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2021.102619_bib129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10975","article-title":"Exploiting a natural conformational switch to engineer an interleukin-2 'superkine","volume":"484","author":"Levin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2021.102619_bib131","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.immuni.2015.04.018","article-title":"Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps","volume":"42","author":"Mitra","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102619_bib132","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.4049\/jimmunol.1800578","article-title":"Engineering a single-agent cytokine\/antibody fusion that selectively expands regulatory T cells for autoimmune disease therapy","volume":"201","author":"Spangler","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102619_bib133","doi-asserted-by":"crossref","first-page":"102591","DOI":"10.1016\/j.jaut.2020.102591","article-title":"Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis","volume":"117","author":"Buitrago-Molina","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102619_bib134","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1002\/anie.201916053","article-title":"Chemical synthesis of interleukin-2 and disulfide stabilizing analogues","volume":"59","author":"Murar","year":"2020","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jaut.2021.102619_bib135","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat. Med."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:28:05Z","timestamp":1760257685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":135,"alternative-id":["S0896841121000275"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102619","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T cells in autoimmune hepatitis: an updated overview","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102619"}}